Loading…
Employees: 1,410
Size Advansix (ASIX) is a United States Materials company (Chemicals: Specialty) with a market value of $454M, the 2768th largest of 3,117 United States companies the cockpit tracks. Shares closed at $16.82 on 6 Nov 2026.
Performance Over six months the shares fell 17.2%, against -14.8% for the median peer and -1.1% for the United States market (cap-weighted) — 11th highest of 21 in its peer set.
Growth Revenue grew 8.4% over the last twelve months (peer median +11.7%); the operating margin is -1.0% (peer median 5.3%).
Valuation It trades at 90.9× forward earnings against a peer median of 9.9× (most expensive of 8).
Price implies For today's price to make sense, revenue must grow about 55% a year for seven years (Req g). Recent delivered growth is +6%, so the hurdle is +50 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
Capital Return on invested capital runs 9.5 points below its cost of capital (8.4% WACC).
Short interest Short interest is 2.2% of the free float (15 Oct 2026).
Next results Next results expected around 12 Feb 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | $1.62B | $1.52B | $1.52B | $1.53B | $1.95B |
| Revenue growth | — | 0% | -1% | -21% | — |
| Gross profit | $73.5M | $174M | $162M | $175M | $327M |
| EBITDA | $68.1M | $147M | $135M | $143M | $296M |
| Net income | -$22.6M | $49.3M | $44.1M | $54.6M | $172M |
| Free cash flow | $3.87M | $6.42M | $1.69M | $10.2M | $184M |
| Capital expenditure | $103M | $116M | $134M | $107M | $89.4M |
| Total debt | $411M | $383M | $351M | $268M | $232M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | ASIX | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +0.7% | -13.4% | 3rd highest of 21 |
| 6-month return | -17.2% | -14.8% | 11th highest of 21 |
| Distance from 52-week high | -37.1% | -39.3% | 9th highest of 21 |
| Revenue growth (TTM) | +8.4% | +11.7% | 9th lowest of 21 |
| Operating margin | -1.0% | 5.3% | 5th lowest of 21 |
| Forward P/E | 90.9× | 9.9× | most expensive of 8 |
| Growth the price implies (Req g, 7 yrs) | 55.3% | 2.0% | most demanding of 16 |
| Growth delivered (Del g) | +5.6% | +3.9% | 8th highest of 16 |
| Hurdle (Req g minus delivered) | +49.6 pp | -10.1 pp | most demanding of 16 |
| ROIC minus cost of capital | -9.5 pp | -1.2 pp | 3rd lowest of 21 |
| Net debt / EBITDA | 5.7× | 0.7× | 2nd most indebted of 9 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Advansix ASIX | United States | $454M | -17% | +8% | -1% | 90.9× | 55.3% | +5.6% |
| Valhi VHI | United States | $456M | +11% | +3% | 1% | 4.6× | 32.2% | +2.3% |
| Changhua Chemical Technology 301518.SZ | China | $452M | -45% | +17% | -2% | n/a | n/a | n/a |
| Braskem S.A. Sponsored ADR Pfd BAK | United States | $457M | -70% | -1% | 1% | 1.0× | n/a | n/a |
| Ho Tung Chemical 1714.TW | Taiwan | $459M | +67% | +36% | 10% | n/a | -17.3% | -1.5% |
| FuJian Nox Bellcow 300132.SZ | China | $459M | -37% | +18% | 7% | 17.9× | 3.1% | -10.5% |
| JSP 7942.T | Japan | $462M | +29% | +14% | 8% | 9.9× | -4.0% | +7.2% |
| Renxin New Material 301395.SZ | China | $445M | -10% | +1% | -6% | n/a | n/a | n/a |
| Nantong Jiangtian Chemical 300927.SZ | China | $463M | -29% | +51% | 5% | n/a | 18.0% | +29.0% |
| UPC Technology 1313.TW | Taiwan | $445M | +4% | -1% | -23% | n/a | -2.6% | +2.5% |
| Shenyang Chemical Industry 000698.SZ | China | $445M | -6% | +18% | 1% | n/a | n/a | n/a |
| Lee & Man Chemical 0746.HK | Hong Kong | $465M | -9% | +3% | 18% | 6.1× | -8.5% | +3.9% |
| Dymatic Chemicals 002054.SZ | China | $465M | -25% | +21% | 8% | n/a | -0.8% | +12.9% |
| Kente Catalysts 603120.SS | China | $465M | +6% | +9% | 12% | n/a | 18.3% | -8.9% |
| Qingdao Copton Technology 603798.SS | China | $443M | -36% | -12% | 5% | n/a | 28.5% | +0.9% |
| Shaanxi Xinghua Chemistry 002109.SZ | China | $473M | -39% | +20% | -1% | n/a | 2.0% | +13.0% |
| Zhejiang Jianye Chemical 603948.SS | China | $436M | -35% | -5% | 12% | n/a | -4.5% | +3.5% |
| Zhejiang Hisun Biomaterials 688203.SS | China | $473M | +16% | +47% | 4% | 56.0× | 16.5% | +26.6% |
| Ellenbarrie Industrial Gases ELLEN.NS | India | $434M | 0% | +289% | 28% | 25.3× | 43.5% | +14.3% |
| Guangdong Delian 002666.SZ | China | $434M | -29% | +5% | 0% | n/a | n/a | n/a |
| Zhejiang Haisen Pharmaceutical 001367.SZ | China | $434M | -20% | +9% | 29% | n/a | -2.1% | +13.4% |